Literature DB >> 12837346

How best to estimate the global burden of pertussis?

N S Crowcroft1, C Stein, P Duclos, M Birmingham.   

Abstract

In most countries, pertussis surveillance is inadequate for accurately estimating numbers of cases or deaths. Good estimates are needed to help set priorities for vaccination programmes. We aimed to develop a simple, reliable, and explicit method for estimating pertussis cases and deaths for children under 15 years to calculate the global disease burden in 1999. We estimated the proportion of susceptible children becoming infected in countries with poor vaccination coverage (<70%) in 1999 at 30% by 1 year, 80% by 5 years, and 100% by 15 years of age and for countries with good coverage (> or =70%) at 10% by 1 year, 60% by 5 years, and 100% by 15 years. Vaccine efficacy was estimated at 80% for preventing infection and 95% for preventing deaths. We used UN population estimates and vaccination coverage reported to WHO (adjusted for specific survey data if available). Case fatality ratios for countries with high and low child mortality were derived from published and unpublished work. For some countries with good vital events registration we used reported deaths adjusted for underascertainment. In 1999 there were an estimated 48.5 million pertussis cases in children worldwide. Deaths from pertussis were estimated at 390000 and at 295000 after adjustment for local data sources. Based on this approach, disability-adjusted life years from pertussis (12.7 million) in 2000 exceeded those of other preventable diseases such as lung cancer (11.4 million) and meningitis (5.8 million). This simple approach yields estimates that can be used for setting vaccination programme priorities. Better data are needed on the public health importance of pertussis in high mortality countries, the benefits of incomplete vaccination, and the harm from delayed vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837346     DOI: 10.1016/s1473-3099(03)00669-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  69 in total

1.  Effectiveness of planning and management interventions for improving age-appropriate immunization in rural India.

Authors:  Shankar Prinja; Madhu Gupta; Amarjeet Singh; Rajesh Kumar
Journal:  Bull World Health Organ       Date:  2009-08-26       Impact factor: 9.408

2.  Immunisation status of children in Germany: temporal trends and regional differences.

Authors:  Helen Kalies; Veit Grote; Heinz-Josef Schmitt; Rüdiger von Kries
Journal:  Eur J Pediatr       Date:  2005-09-14       Impact factor: 3.183

3.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

5.  The RNA chaperone Hfq is required for virulence of Bordetella pertussis.

Authors:  Ilona Bibova; Karolina Skopova; Jiri Masin; Ondrej Cerny; David Hot; Peter Sebo; Branislav Vecerek
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

6.  Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

Authors:  Jennie S Lavine; Aaron A King; Ottar N Bjørnstad
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 7.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

8.  Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis.

Authors:  Claudia Guevara; Chengxian Zhang; Jennifer A Gaddy; Junaid Iqbal; Julio Guerra; David P Greenberg; Michael D Decker; Nicholas Carbonetti; Timothy D Starner; Paul B McCray; Frits R Mooi; Oscar G Gómez-Duarte
Journal:  Infect Dis (Lond)       Date:  2015-10-22

9.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

10.  Estimating the duration of pertussis immunity using epidemiological signatures.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.